Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Toppari, Jorma


IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

Online
ISSN
2191-0251
See all formats and pricing
More options …
Volume 29, Issue 1

Issues

An adolescent girl referred with Cushing syndrome – does she or does she not have the syndrome?

Kung-Ting Kao
  • Corresponding author
  • Department of Endocrinology and Diabetes, Royal Children’s Hospital, Flemington Road, Parkville, Victoria 3052, Australia
  • Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
  • University of Melbourne, Victoria, Australia
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Margaret Zacharin
  • Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
  • University of Melbourne, Victoria, Australia
  • The Royal Children’s Hospital, Melbourne, Victoria, Australia
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-12-17 | DOI: https://doi.org/10.1515/jpem-2015-0231

Abstract

Cushing syndrome and lipodystrophy syndromes share similar clinical features. This report describes an adolescent girl with newly diagnosed familial partial lipodystrophy type 2 (FPLD2) who was initially referred for Cushing syndrome. The type of abnormal fat deposition syndrome can be elucidated by careful clinical examination. FPLD2 can lead to type 2 diabetes mellitus and early cardiovascular events. Partial lipodystrophy presenting for the first time in adolescence can be mistaken for corticosteroid excess. Early diagnosis and preventative management of cardiovascular risk factors are crucial.

Keywords: adolescent; Cushing syndrome; insulin resistance; laminopathy; lipodystrophy

References

  • 1.

    Garg A. Lipodystrophies. Am J Med 2000;108:143–52.Google Scholar

  • 2.

    Gupta SK, Dube MP. Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy. Clin Infect Dis 2002;35:69–71.Google Scholar

  • 3.

    Krause JC, Toye MP, Fisher DJ, Stechenberg BW, Reiter EO, et al. Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-up. J Pediatr Endocrinol Metab 2009;22:345–51.CrossrefGoogle Scholar

  • 4.

    Savage MO, Storr HL. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome. J Pediatr Endocrinol Metab 2014;27:1029–31.Web of ScienceGoogle Scholar

  • 5.

    Garg A. Clinical review: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313–25.CrossrefGoogle Scholar

  • 6.

    Gao J, Li Y, Fu X, Luo X. A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene. J Pediatr Endocrinol Metab 2012;25:375–7.Web of ScienceCrossrefGoogle Scholar

  • 7.

    De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002;70:726–36.Google Scholar

  • 8.

    Subramanyam L, Simha V, Garg A. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations. Clin Genet 2010;78:66–73.Web of ScienceCrossrefGoogle Scholar

  • 9.

    Carboni N, Politano L, Floris M, Mateddu A, Solla E, et al. Overlapping syndromes in laminopathies: a meta-analysis of the reported literature. Acta Myol 2013;32:7–17.Google Scholar

  • 10.

    Green LN. Progeria with carotid artery aneurysms: report of a case. Arch Neurol 1981;38:659–61.Google Scholar

  • 11.

    Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 2007;56:508–16.CrossrefWeb of ScienceGoogle Scholar

  • 12.

    Hughes JM, Stephen C, Johnson AB, Wilson S. Breast augmentation in familial partial lipodystrophy: a case report. J Plast Reconstr Aesthet Surg 2011;64:121–4.Web of ScienceGoogle Scholar

  • 13.

    Ion L, Raveendran SS. Open neck lipectomy for patients with HIV-related cervical lipohypertrophy. Aesthetic Plast Surg 2011;35:953–9.Google Scholar

  • 14.

    Nelson L, Stewart KJ. Experience in the treatment of HIV-associated lipodystrophy. J Plast Reconstr Aesthet Surg 2008;61:366–71.Web of ScienceGoogle Scholar

About the article

Corresponding author: Dr. Kung-Ting Kao, MBChB, Department of Endocrinology and Diabetes, Royal Children’s Hospital, Flemington Road, Parkville, Victoria 3052, Australia, Phone: + 61 3 9345 5951, Fax: + 61 3 9345 6240, E-mail: ; Murdoch Children’s Research Institute, Melbourne, Victoria, Australia; and University of Melbourne, Victoria, Australia


Received: 2015-06-10

Accepted: 2015-07-06

Published Online: 2015-12-17

Published in Print: 2016-01-01


Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 29, Issue 1, Pages 109–112, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2015-0231.

Export Citation

©2016 by De Gruyter.Get Permission

Comments (0)

Please log in or register to comment.
Log in